Bayer raises first equity component of Monsanto deal funding
19:13 PM | November 16, 2016 | Natasha Alperowicz
Bayer said Wednesday it has completed placing €4 billion ($4 billion) in mandatory convertible notes with institutional investors excluding the preemptive rights of the shareholders of Bayer AG.
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.